Jin Medical International (ZJYL) Invested Capital (2022 - 2025)
Jin Medical International's Invested Capital history spans 4 years, with the latest figure at $18.8 million for Q3 2025.
- For Q3 2025, Invested Capital rose 34.53% year-over-year to $18.8 million; the TTM value through Sep 2024 reached $14.0 million, down 50.16%, while the annual FY2025 figure was $18.8 million, 34.53% up from the prior year.
- Invested Capital for Q3 2025 was $18.8 million at Jin Medical International, up from $14.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $28.1 million in Q3 2023 and bottomed at $14.0 million in Q3 2024.
- The 4-year median for Invested Capital is $17.0 million (2022), against an average of $19.0 million.
- The largest annual shift saw Invested Capital surged 84.38% in 2023 before it plummeted 50.16% in 2024.
- A 4-year view of Invested Capital shows it stood at $15.2 million in 2022, then soared by 84.38% to $28.1 million in 2023, then tumbled by 50.16% to $14.0 million in 2024, then surged by 34.53% to $18.8 million in 2025.
- Per Business Quant, the three most recent readings for ZJYL's Invested Capital are $18.8 million (Q3 2025), $14.0 million (Q3 2024), and $28.1 million (Q3 2023).